GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **801 - 825** of **4050** in total

« First

‹ Prev

…

29

30

31

32

33

34

35

36

37

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgG	Patient 3	-180	mild	G66937TJ	48
IgG	Patient 3	-180	mild	G96557TJ	48
IgG	Patient 3	11	mild	G00048MO	48
IgG	Patient 3	11	mild	G25473LQ	48
IgG	Patient 3	11	mild	G78255UI	48
IgG	Patient 3	4	mild	G21320TF	48
IgG	Patient 3	4	mild	G38488WF	48
IgG	Patient 3	4	mild	G90223GH	48
IgG	Patient 4	12	mild	G72739GY	48
IgG	Patient 4	12	mild	G90223GH	48
IgG	Patient 1	22	moderate	G14988WV	49
IgM	Patient 1	10	moderate	G51175PR	49
IgM	Patient 1	22	moderate	G64669AQ	49
IgM	Patient 1	6	moderate	G10789DJ	49
IgM	Patient 1	6	moderate	G51175PR	49
IgM	Patient 1	6	moderate	G71469XA	49
IgG	Patient 2	15	mild	G09482NW	49
IgG	Patient 2	24	mild	G58969RU	49
IgG	Patient 3	-180	mild	G00065MO	49
IgG	Patient 3	-180	mild	G09482NW	49
IgG	Patient 3	-180	mild	G25407RZ	49
IgG	Patient 3	-180	mild	G61751GZ	49
IgG	Patient 3	-180	mild	G94576MN	49
IgG	Patient 3	11	mild	G22768VO	49
IgG	Patient 3	4	mild	G76355TG	49